Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C65152
http://purl.obolibrary.org/obo/NCIT_C65152
|
|---|---|
| Preferred Name | Soy Isoflavones |
| Definitions |
A dietary supplement isolated from soybeans containing phytoestrogen isoflavones. Although the mechanism of action is unclear, soy isoflavones mimic estrogen action mediated through estrogen receptors. In addition, this agent also modulates estrogen metabolism. As a result, soy isoflavones have been shown to reduce tumor cell proliferation and induce tumor cell apoptosis, as well as to be able to regulate hormone balance and reduce the risks of breast cancer, heart disease, and osteoporosis.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A dietary supplement isolated from soybeans containing phytoestrogen isoflavones. Although the mechanism of action is unclear, soy isoflavones mimic estrogen action mediated through estrogen receptors. In addition, this agent also modulates estrogen metabolism. As a result, soy isoflavones have been shown to reduce tumor cell proliferation and induce tumor cell apoptosis, as well as to be able to regulate hormone balance and reduce the risks of breast cancer, heart disease, and osteoporosis. |
|---|---|
| prefLabel | Soy Isoflavones
|
| label | Soy Isoflavones
|
| PDQ_Closed_Trial_Search_ID | 466602
|
| code | C65152
|
| prefixIRI | NCIT:C65152
|
| in_subset |
See more
See less
|
| Display_Name | Soy Isoflavones
|
| Preferred_Name | Soy Isoflavones
|
| FDA_UNII_Code | 71B37NR06D
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Soy Isoflavones
|
| NCI_Drug_Dictionary_ID | 466602
|
| Legacy Concept Name | Soy_Isoflavones
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 466602
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C4076257
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |